share_log

Novo-Nordisk A/S | 6-K: Novo Nordisk A/S - Share Repurchase Programme

SEC announcement ·  Feb 22 06:11
Summary by Moomoo AI
Novo Nordisk A/S, a leading global healthcare company, has announced the continuation of its share repurchase program, which began on February 6, 2024. The program is part of a larger 12-month initiative to buy back shares worth up to DKK 20 billion, which started on the same date in 2023. As of February 19, 2024, the company has repurchased 394,500 B shares at an average price of DKK 830.60, totaling DKK 327,673,060. This buyback is in line with the Safe Harbour Rules of the European Union. Novo Nordisk, which has a strong heritage in diabetes care, is committed to defeating serious chronic diseases and employs approximately 63,400 people worldwide. The company's B shares are traded on Nasdaq Copenhagen, and its ADRs are listed on the New York Stock Exchange.
Novo Nordisk A/S, a leading global healthcare company, has announced the continuation of its share repurchase program, which began on February 6, 2024. The program is part of a larger 12-month initiative to buy back shares worth up to DKK 20 billion, which started on the same date in 2023. As of February 19, 2024, the company has repurchased 394,500 B shares at an average price of DKK 830.60, totaling DKK 327,673,060. This buyback is in line with the Safe Harbour Rules of the European Union. Novo Nordisk, which has a strong heritage in diabetes care, is committed to defeating serious chronic diseases and employs approximately 63,400 people worldwide. The company's B shares are traded on Nasdaq Copenhagen, and its ADRs are listed on the New York Stock Exchange.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more